Evidence map›Paper›PMID 25821788›Full record

ArticleBioMed research international2015

Cytotoxicity of cyclodipeptides from Pseudomonas aeruginosa PAO1 leads to apoptosis in human cancer cell lines.

Dolores Vázquez-Rivera, Omar González, Jaquelina Guzmán-Rodríguez, Alma L Díaz-Pérez, Alejandra Ochoa-Zarzosa, José López-Bucio, Víctor Meza-Carmen, Jesús Campos-García

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Chemical profiling and cytotoxic activity of the endophytic fungus Epicoccum sorghinum isolated from Disynaphia filifolia.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Frontiers in oncology · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Bioactive Potential of Extracts ofMolecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dolores Vázquez-RiveraInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Edificio B-3, Ciudad Universitaria, 58030 Morelia, MICH, Mexico.
Omar GonzálezInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Edificio B-3, Ciudad Universitaria, 58030 Morelia, MICH, Mexico.
Jaquelina Guzmán-RodríguezCentro Multidisciplinario de Estudios en Biotecnología, Facultad de Medicina Veterinaria y Zootécnia, UMSNH, 58893 Morelia, MICH, Mexico.
Alma L Díaz-PérezInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Edificio B-3, Ciudad Universitaria, 58030 Morelia, MICH, Mexico.
Alejandra Ochoa-ZarzosaCentro Multidisciplinario de Estudios en Biotecnología, Facultad de Medicina Veterinaria y Zootécnia, UMSNH, 58893 Morelia, MICH, Mexico.
José López-BucioInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Edificio B-3, Ciudad Universitaria, 58030 Morelia, MICH, Mexico.
Víctor Meza-CarmenInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Edificio B-3, Ciudad Universitaria, 58030 Morelia, MICH, Mexico.
Jesús Campos-GarcíaInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo (UMSNH), Edificio B-3, Ciudad Universitaria, 58030 Morelia, MICH, Mexico.
Universidad Michoacana de San Nicolás de Hidalgo · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen of plants and animals, which produces virulence factors in order to infect or colonize its eukaryotic hosts. Cyclodipeptides (CDPs) produced by P. aeruginosa exhibit cytotoxic properties toward human tumor cells. In this study, we evaluated the effect of a CDP mix, comprised of cyclo(L-Pro-L-Tyr), cyclo(L-Pro-L-Val), and cyclo(L-Pro-L-Phe) that were isolated from P. aeruginosa, on two human cancer cell lines. Our results demonstrated that the CDP mix promoted cell death in cultures of the HeLa cervical adenocarcinoma and Caco-2 colorectal adenocarcinoma cell lines in a dose-dependent manner, with a 50% inhibitory concentration (IC50) of 0.53 and 0.66 mg/mL, for HeLa and Caco-2 cells, respectively. Flow cytometric analysis, using annexin V and propidium iodide as apoptosis and necrosis indicators, respectively, clearly showed that HeLa and Caco-2 cells exhibited apoptotic characteristics when treated with the CDP mix at a concentration <0.001 mg/mL. IC50 values for apoptotic cells in HeLa and Caco-2 cells were 6.5 × 10(-5) and 1.8 × 10(-4) mg/mL, respectively. Our results indicate that an apoptotic pathway is involved in the inhibition of cell proliferation caused by the P. aeruginosa CDP mix.

Indexed as

Antineoplastic AgentsApoptosisCaco-2 CellsCell Line, TumorDipeptidesDose-Response Relationship, DrugHeLa CellsHumansNeoplasms, ExperimentalPseudomonas aeruginosaSpecies SpecificityAntineoplastic AgentsDipeptides

Identifiers

PMID25821788
PMCPMC4363556
OpenAlexW1981026235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.